IE40226B1 - M-dioxane-5-methylamine analgesics - Google Patents

M-dioxane-5-methylamine analgesics

Info

Publication number
IE40226B1
IE40226B1 IE2190/73A IE219073A IE40226B1 IE 40226 B1 IE40226 B1 IE 40226B1 IE 2190/73 A IE2190/73 A IE 2190/73A IE 219073 A IE219073 A IE 219073A IE 40226 B1 IE40226 B1 IE 40226B1
Authority
IE
Ireland
Prior art keywords
formula
image
analgesics
methylamine
dioxane
Prior art date
Application number
IE2190/73A
Other versions
IE40226L (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to IE2342/77A priority Critical patent/IE40227B1/en
Publication of IE40226L publication Critical patent/IE40226L/en
Publication of IE40226B1 publication Critical patent/IE40226B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The m-dioxanes correspond to the formula I <IMAGE> the meanings of the symbols being given in Patent Claim 1. The compounds, as well as those which have been partially demethylated at the amine nitrogen, exhibit an excellent analgesic action without producing addiction in the treated patient. The compounds are prepared by reacting a ketone of the formula II <IMAGE> with an amine of the formula <IMAGE> and reducing the resulting enamine catalytically in the presence of hydrogen to give a compound of the formula I. [GB1455997A]
IE2190/73A 1972-12-08 1973-12-04 M-dioxane-5-methylamine analgesics IE40226B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE2342/77A IE40227B1 (en) 1972-12-08 1973-12-04 2-(-(substituted) amino-benzyl)-1,3-propanediols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
IE40226L IE40226L (en) 1974-06-08
IE40226B1 true IE40226B1 (en) 1979-04-11

Family

ID=23214841

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2190/73A IE40226B1 (en) 1972-12-08 1973-12-04 M-dioxane-5-methylamine analgesics

Country Status (27)

Country Link
JP (2) JPS5742633B2 (en)
AR (3) AR206306A1 (en)
AT (2) AT330773B (en)
BE (1) BE808340A (en)
BG (4) BG21409A3 (en)
CA (2) CA1014560A (en)
CH (4) CH605903A5 (en)
CS (3) CS193480B2 (en)
CY (1) CY1017A (en)
DD (3) DD110864A5 (en)
DE (1) DE2361340C2 (en)
DK (1) DK134717B (en)
ES (4) ES421290A1 (en)
FR (1) FR2209578B1 (en)
GB (2) GB1455997A (en)
HK (1) HK60479A (en)
HU (2) HU168763B (en)
IE (1) IE40226B1 (en)
IL (1) IL43773A (en)
KE (1) KE2976A (en)
MY (1) MY8000064A (en)
NL (1) NL7316839A (en)
PH (2) PH15197A (en)
SE (3) SE403377B (en)
SU (4) SU578001A3 (en)
YU (3) YU35447B (en)
ZA (1) ZA739207B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6030752B2 (en) * 2012-05-09 2016-11-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for producing oxetane-3-ylmethanamine
LV14983B (en) * 2013-10-15 2015-06-20 Olainfarm, A/S Method for producing intermediates of phenibut

Also Published As

Publication number Publication date
CS193480B2 (en) 1979-10-31
BG21223A3 (en) 1976-03-20
MY8000064A (en) 1980-12-31
SU578001A3 (en) 1977-10-25
CS222209B2 (en) 1983-05-27
BG22386A3 (en) 1977-02-20
AU6321773A (en) 1975-06-05
BG21409A3 (en) 1976-05-20
CH605903A5 (en) 1978-10-13
CH619219A5 (en) 1980-09-15
SE428378B (en) 1983-06-27
ES444716A1 (en) 1977-05-16
AR212416A1 (en) 1978-07-14
YU318473A (en) 1980-09-25
ATA1026073A (en) 1975-10-15
SE7701795L (en) 1977-02-17
AR206306A1 (en) 1976-07-15
SE417196B (en) 1981-03-02
ES444911A1 (en) 1977-09-01
SU587861A3 (en) 1978-01-05
DD115653A5 (en) 1975-10-12
CS222208B2 (en) 1983-05-27
HK60479A (en) 1979-08-31
CA1014560A (en) 1977-07-26
YU36020B (en) 1981-11-13
DE2361340C2 (en) 1983-11-24
JPS5734835B2 (en) 1982-07-26
BG26205A4 (en) 1979-02-15
ES421290A1 (en) 1976-07-01
FR2209578B1 (en) 1977-09-02
DK134717B (en) 1977-01-03
SU663305A3 (en) 1979-05-15
IL43773A0 (en) 1974-03-14
CY1017A (en) 1979-11-23
JPS5742633B2 (en) 1982-09-09
ES421291A1 (en) 1976-07-01
DD109625A5 (en) 1974-11-12
CH630914A5 (en) 1982-07-15
CH614439A5 (en) 1979-11-30
YU109380A (en) 1981-04-30
KE2976A (en) 1979-07-20
AT332396B (en) 1976-09-27
CA1024150A (en) 1978-01-10
BE808340A (en) 1974-06-07
YU35447B (en) 1981-02-28
PH15197A (en) 1982-09-17
SU648081A3 (en) 1979-02-15
HU168763B (en) 1976-07-28
NL7316839A (en) 1974-06-11
AR212012A1 (en) 1978-04-28
DD110864A5 (en) 1975-01-12
JPS4987681A (en) 1974-08-22
IE40226L (en) 1974-06-08
SE7701796L (en) 1977-02-17
SE403377B (en) 1978-08-14
DK134717C (en) 1977-05-31
HU168620B (en) 1976-06-28
DE2361340A1 (en) 1974-06-12
JPS4987680A (en) 1974-08-22
GB1455997A (en) 1976-11-17
PH14923A (en) 1982-01-29
AT330773B (en) 1976-07-26
ATA1026173A (en) 1976-01-15
ZA739207B (en) 1975-07-30
IL43773A (en) 1979-05-31
YU318573A (en) 1981-06-30
GB1455998A (en) 1976-11-17
YU36171B (en) 1982-02-25
FR2209578A1 (en) 1974-07-05

Similar Documents

Publication Publication Date Title
IE35283B1 (en) Substituted benzylimidazolidinones and a process for the manufacture thereof
ES450536A1 (en) Chroman-4-ones and process for preparing same
IE42977L (en) Triaryl-piperidine methanols.
IE40226B1 (en) M-dioxane-5-methylamine analgesics
ES424851A1 (en) A procedure for preparing piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
ES8302733A1 (en) Novel anthracycline derivative, process for production thereof, and pharmaceutical composition comprising said compound.
ES450897A1 (en) N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic compositions and methods employing them
ES458812A1 (en) Novel benzo *c* quinolines
IE38139B1 (en) New 1-ethyl-imidazoles their production and their medicinal use
IE37717L (en) N-BENZHYDRYL-N&#39;-p-HYDROXYBENZYL-PIPERAZINES.
ES447664A1 (en) Cardenolide derivatives
JPS5655382A (en) Manufacture of ciss2*66dimethylmorpholine
GB1436377A (en) Isoquinoline derivatives
ES423289A1 (en) N-formyl and N-desmethyl leurosine derivatives
IE38320L (en) Nor-morphines and nor-codeines
JPS5223518A (en) Steel of extremeiy low yield point with excellent workability and non- aging property and production
JPS52718A (en) Process for producing magnets containing rare earth elements
JPS5247988A (en) Method of producing l-tartaric acid
GB1437149A (en) Spiro-compounds and a process for their preparation
JPS523068A (en) Novel method of preparing 3-(3-methyl-2-butenyl)-1,2,3,4,5,6-hexahydro -6,11- dimethyl-8-hydroxy-2,6-methano-3-benzazocine
ES409555A1 (en) A procedure for the obtaining of new derivatives of cefalosporine. (Machine-translation by Google Translate, not legally binding)
JPS52148083A (en) Preparation of piperidine
IE45456L (en) Aminoalkyl furan derivatives
ES410007A1 (en) A procedure for the preparation of 1-ethyl-1-alcoxycarbonyl-ethyl-1, 2, 3, 4, 6, 6, 12, 12b-octahidro-indol- (2, 3a) quinolicinas. (Machine-translation by Google Translate, not legally binding)
ES444539A1 (en) Process for the preparation of 3,4,5-trimethoxy-phenyl-(1,4-dimethyl-1,2,3,6-tetrahydro-2-pyridyl)-carbinol